ScholarshipAir
Menu
Subscribe for scholarship alert.
Be among the first to know whenever new Novartis AG scholarship is going on. Enter your email address and click the Subscribe button ↓
Like our website? Follow us on Facebook

Funding Opportunities at Novartis AG

      • HealthTech Hub Africa (HTHA) Accelerator Program 2024

      • The HealthTech Hub Africa is a hybrid pan-African healthtech accelerator, with a physical co-working and community space in Kigali, Rwanda, working to drive development of health technologies in Africa and fast-track these innovations in public health systems through collaboration with government pa ... read more and apply

Novartis AG is a Swiss multinational pharmaceutical corporation based in Basel, Switzerland. Consistently ranked in the global top five, Novartis is one of the largest pharmaceutical companies in the world and was the fourth largest by revenue in 2022.

Novartis manufactures the drugs clozapine (Clozaril), diclofenac (Voltaren; sold to GlaxoSmithKline in 2015 deal), carbamazepine (Tegretol), valsartan (Diovan), imatinib mesylate (Gleevec/Glivec), cyclosporine (Neoral/Sandimmune), letrozole (Femara), methylphenidate (Ritalin; production ceased 2020), terbinafine (Lamisil), deferasirox (Exjade), and others.

Novartis was formed in 1996 by the merger of Ciba-Geigy and Sandoz.It was considered the largest corporate merger in history during that time.[6] The pharmaceutical and agrochemical divisions of both companies formed Novartis as an independent entity. The name Novartis was based on the Latin terms, “novae artes” (new skills).[6]